Lysophosphatidic acid acyltransferase-alpha (LPAAT-α), encoded by the gene AGPAT1, is an integral membrane enzyme that plays a pivotal role in the biosynthesis of glycerolipids. This enzyme is chiefly responsible for the acylation of lysophosphatidic acid (LPA) at the sn-2 position, leading to the production of phosphatidic acid (PA), a vital intermediate in the synthesis of both triglycerides and glycerophospholipids. The enzymatic activity of LPAAT-α is essential for maintaining the structural integrity of cellular membranes and for the generation of lipid signaling molecules. The expression of LPAAT-α can be subject to regulation by a variety of biological processes and is sensitive to alterations in cellular metabolic states, nutritional availability, and extracellular signals.
Interest in the regulation of LPAAT-α expression has led to the identification of several chemical compounds that can act as activators, each interacting with distinct cellular pathways to potentially stimulate the production of this enzyme. For example, forskolin, by way of increasing intracellular cAMP levels, can initiate a signaling cascade that culminates in the activation of transcription factors that promote LPAAT-α gene transcription. Similarly, compounds like retinoic acid and phorbol esters, such as PMA, have been noted to interact with nuclear receptors and kinase pathways respectively, thereby potentially enhancing the expression of LPAAT-α. Other molecules, like the histone deacetylase inhibitor sodium butyrate, can alter chromatin structure, thereby increasing gene accessibility and facilitating the transcription of LPAAT-α. Additionally, certain fatty acids, including eicosapentaenoic acid, have been observed to interact with transcription factors such as PPARs, which may lead to an induction of LPAAT-α expression as part of the intricate feedback mechanisms governing lipid homeostasis and metabolism. Each of these compounds engages with the cellular machinery in a unique manner, highlighting the diverse regulatory environment that governs the expression of enzymes crucial for lipid biosynthesis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin may upregulate LPAAT-α expression by elevating intracellular cAMP, which can activate CREB, a transcription factor known to stimulate gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could stimulate LPAAT-α transcription by binding to nuclear receptors that bind DNA at specific sequences to initiate transcription. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA may increase LPAAT-α expression by mimicking diacylglycerol, thus activating PKC which can trigger a cascade of events leading to transcriptional activation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine could induce demethylation of the LPAAT-α gene promoter, leading to a subsequent rise in its expression. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea can stimulate the transcription of LPAAT-α by causing ribonucleotide reductase inhibition, which may alter the balance of nucleotides and affect transcription processes. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride could promote LPAAT-α expression by inhibiting GSK-3, which in turn may activate transcription factors and elevate gene transcription. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate may upregulate LPAAT-α by inhibiting histone deacetylases, resulting in a more open chromatin structure and increased accessibility for transcription machinery. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol can stimulate LPAAT-α expression through its agonistic effect on β-adrenergic receptors, thereby increasing intracellular cAMP and activating transcriptional activity. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $104.00 $431.00 | ||
EPA may upregulate LPAAT-α as part of a feedback mechanism in lipid metabolism by activating peroxisome proliferator-activated receptors (PPARs) which can induce gene expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol could stimulate the upregulation of LPAAT-α through the activation of SIRT1, leading to deacetylation of transcription factors and enhanced transcription. | ||||||